Back

Cardiovascular toxicity of ibrutinib: a pharmacovigilance study.

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Use benefit and risk of pharmacotherapy Cardiotoxicity of Drugs ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Joe Elie Salem

Sorbonne University, Paris (France)

6 More presentations in this session

Presentation thumbnail
Professor A. Kane (Saint-Louis, SN)
Abstract Slides
Presentation thumbnail
Doctor A. Mohammad (Hyderabad, IN)
Abstract
Presentation thumbnail
Doctor H. Holm (Malmo, SE)
Abstract
Presentation thumbnail
Doctor J. Sousa (Porto, PT)
Abstract Slides
Presentation thumbnail
Professor C. Chen (Wuhan, CN)

Access the full session

Session thumbnail
Poster Session 2 - Use benefit and risk of pharmacotherapy

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Webinar
Multidisciplinary strategies for monitoring and managing cardiovascular toxicity in patients with cancer
thumbnail
Congress Session
Recent perspectives in cardio-oncology
thumbnail
Congress Session
Cardio-oncology: when therapy leads to failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources